Skip Nav Destination
Issues
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Review
Advances in Brief
A Gene Expression Signature Associated with Metastatic Outcome in Human Leiomyosarcomas
Yin-Fai Lee; Megan John; Alison Falconer; Sandra Edwards; Jeremy Clark; Penny Flohr; Toby Roe; Rubin Wang; Janet Shipley; Robert J. Grimer; D. Chas Mangham; J. Meirion Thomas; Cyril Fisher; Ian Judson; Colin S. Cooper
p53-Binding Protein 1 Is Fused to the Platelet-Derived Growth Factor Receptor β in a Patient with a t(5;15)(q33;q22) and an Imatinib-Responsive Eosinophilic Myeloproliferative Disorder
Francis H. Grand; Sonja Burgstaller; Thomas Kühr; E. Joanna Baxter; Gerald Webersinke; Josef Thaler; Andrew J. Chase; Nicholas C. P. Cross
Molecular Biology, Pathobiology, and Genetics
Cell and Tumor Biology
PAX5 Expression in Acute Leukemias: Higher B-Lineage Specificity Than CD79a and Selective Association with t(8;21)-Acute Myelogenous Leukemia
Enrico Tiacci; Stefano Pileri; Annette Orleth; Roberta Pacini; Alessia Tabarrini; Federica Frenguelli; Arcangelo Liso; Daniela Diverio; Francesco Lo-Coco; Brunangelo Falini
Gene Expression of Parathyroid Tumors: Molecular Subclassification and Identification of the Potential Malignant Phenotype
Carola J. Haven; Viive M. Howell; Paul H. C. Eilers; Robert Dunne; Masayuki Takahashi; Marjo van Puijenbroek; Kyle Furge; Job Kievit; Min-Han Tan; Gert Jan Fleuren; Bruce G. Robinson; Leigh W. Delbridge; Jeanette Philips; Anne E. Nelson; Ulf Krause; Henning Dralle; Cuong Hoang-Vu; Oliver Gimm; Hans Morreau; Deborah J. Marsh; Bin T. Teh
HIV-1 Protease Inhibitor, Ritonavir: A Potent Inhibitor of CYP3A4, Enhanced the Anticancer Effects of Docetaxel in Androgen-Independent Prostate Cancer Cells In vitro and In vivo
Takayuki Ikezoe; Yasuko Hisatake; Tamotsu Takeuchi; Yuji Ohtsuki; Yang Yang; Jonathan W. Said; Hirokuni Taguchi; H. Phillip Koeffler
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Gefitinib Enhances the Antitumor Activity and Oral Bioavailability of Irinotecan in Mice
Clinton F. Stewart; Markos Leggas; John D. Schuetz; John C. Panetta; Pamela J. Cheshire; Jennifer Peterson; Najat Daw; Jesse J. Jenkins, III; Richard Gilbertson; Glen S. Germain; Franklin C. Harwood; Peter J. Houghton
Caveolin-1 Is Required for Vascular Endothelial Growth Factor-Triggered Multiple Myeloma Cell Migration and Is Targeted by Bortezomib
Klaus Podar; Reshma Shringarpure; Yu-Tzu Tai; Melissa Simoncini; Martin Sattler; Kenji Ishitsuka; Paul G. Richardson; Teru Hideshima; Dharminder Chauhan; Kenneth C. Anderson
Blockade of Paclitaxel-Induced Thymidine Phosphorylase Expression Can Accelerate Apoptosis in Human Prostate Cancer Cells
Nobuyuki Kikuno; Nobuko Moriyama-Gonda; Tateki Yoshino; Tatsuaki Yoneda; Shinji Urakami; Masaharu Terashima; Manabu Yoshida; Hirofumi Kishi; Kazushi Shigeno; Hiroaki Shiina; Mikio Igawa
Inhibition of Smoothened Signaling Prevents Ultraviolet B-Induced Basal Cell Carcinomas through Regulation of Fas Expression and Apoptosis
Mohammad Athar; Chengxin Li; Xiuwei Tang; Sumin Chi; Xiaoli Zhang; Arianna L. Kim; Stephen K. Tyring; Levy Kopelovich; Jennifer Hebert; Ervin H. Epstein, Jr.; David R. Bickers; Jingwu Xie
c-Jun NH2-Terminal Kinase-Mediated Up-regulation of Death Receptor 5 Contributes to Induction of Apoptosis by the Novel Synthetic Triterpenoid Methyl-2-Cyano-3,12-Dioxooleana-1, 9-Dien-28-Oate in Human Lung Cancer Cells
Wei Zou; Xiangguo Liu; Ping Yue; Zhongmei Zhou; Michael B. Sporn; Reuben Lotan; Fadlo R. Khuri; Shi-Yong Sun
Immunology
CC Chemokine Ligand 25 Enhances Resistance to Apoptosis in CD4+ T Cells from Patients with T-Cell Lineage Acute and Chronic Lymphocytic Leukemia by Means of Livin Activation
Zhang Qiuping; Xiong Jei; Jin Youxin; Ju Wei; Liu Chun; Wang Jin; Wu Qun; Liu Yan; Hu Chunsong; Yang Mingzhen; Gao Qingping; Zhang Kejian; Sun Zhimin; Li Qun; Liu Junyan; Tan Jinquan
Anti–HER-2/neu Immune Responses Are Induced before the Development of Clinical Tumors but Declined following Tumorigenesis in HER-2/neu Transgenic Mice
Noritami Takeuchi; Shin-ichiroh Hiraoka; Xu-Yu Zhou; Masakazu Nagafuku; Shiro Ono; Takahiro Tsujimura; Mitsuhiro Nakazawa; Yoshiaki Yura; Toshiyuki Hamaoka; Hiromi Fujiwara
RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates Tumorigenicity In vivo
Manuel A. Friese; Jörg Wischhusen; Wolfgang Wick; Markus Weiler; Günter Eisele; Alexander Steinle; Michael Weller
Endocrinology
Clinical Research
Epidemiology and Prevention
Meeting Report
Correction
Advertisement
